Nerofe

Grant application to support clinical trial for treatment of Alzheimer’s diseaseApril 13, 2021

ISK Ltd and Harvard medical school submitted together grant application to support phase 1B clinical trial for treatment of Alzheimer’s disease.

13 Apr|

PHASE 1B/2A Clinical trial started

The Nerofe Phase 1B/2A trial with high risk MDS and AML patients is taking place at the University of Miami Sylvester Comprehensive Cancer Center.

13 Apr|

New Article Published: Nerofe Phase I trial summaryDecember 11, 2017

The Phase I Nerofe (dTCApFs) human trial summary has been published in the Molecular and Clinical Oncology Journal.

In this trial Nerofe was found to be safe and well‑tolerated, and potentially efficacious as an anti-cancer agent.

11 Dec|

Successful completion of Phase I Nerofe Trial on Solid tumorsNovember 21, 2017

Successful completion of Phase I Nerofe Trial on Solid tumors

21 Nov|

Nerofe Pre-clinical Paper Published in Molecular and Clinical Oncology JournalOctober 21, 2017

Link To Article

21 Oct|